 | Up a level |
Brechmann, Markus, Mock, Thomas, Nickles, Dorothee, Kiessling, Michael, Weit, Nicole, Breuer, Rebecca, Mueller, Wolfgang, Wabnitz, Guido 
ORCID: 0000-0001-5101-9885, Frey, Felice, Nicolay, Jan P., Booken, Nina, Samstag, Yvonne, Klemke, Claus-Detlev, Herling, Marco, Boutros, Michael ORCID: 0000-0002-9458-817X, Krammer, Peter H. and Arnold, Ruediger
(2012).
A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes.
Immunity, 37 (4).
S. 697 - 709.
CAMBRIDGE:
CELL PRESS.
ISSN 1074-7613
Pflug, Natali, Hopfinger, Georg, Cramer, Paula, Schrader, Alexandra, Weit, Nicole, Meister, Rita, Thiel, Miriam, Annolleck, Tanja, Westermann, Anne, Seiler, Till M., Zenz, Thorsten, Duerig, Jan, Bahlo, Jasmin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Fink, Anna-Maria, Eichhorst, Barbara, Hallek, Michael and Herling, Marco (2014). Induction Treatment with Alemtuzumab Combined with Polychemotherapy Containing Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Followed By Alemtuzumab Maintenance in Patients with T-Cell Prolymphocytic Leukaemia (T-PLL): First Analysis of a Prospective Multicenter Phase-II-Trial (T-PLL2) Conducted By the German CLL Study Group (GCLLSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Warner, Kathrin, Crispatzu, Giuliano, Al-Ghaili, Nabil, Weit, Nicole, Florou, Vaia, You, M. James, Newrzela, Sebastian and Herling, Marco (2013). Models for mature T-cell lymphomas-A critical appraisal of experimental systems and their contribution to current T-cell tumorigenic concepts. Crit. Rev. Oncol./Hematol., 88 (3). S. 680 - 696. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-0461